AIxCrypto Holdings Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
AIxCrypto Holdings Inc
CIK #0001460702
EDGAR Form CIK 2011 - 2026
10-K [0001460702]
10-Q [0001460702]
3 [0001460702]
4 [0001460702]
8-K [0001460702]
D [0001460702]
SC 13D [0001460702]
SC 13G [0001460702]
Form 13D/13G Filer Form 13D/13G Subject Filed
Faraday Future Intelligent Electric Inc Qualigen Therapeutics Inc [2025-11-12]
Sabby Management LLC Qualigen Therapeutics Inc [2021-12-06]
Greenblock Capital LLC Qualigen Therapeutics Inc [2020-06-01]
Sekisui Diagnostics LLC Qualigen Therapeutics Inc [2020-06-01]
Alpha Capital Anstalt Qualigen Therapeutics Inc [2020-05-28]
Baker Bros Advisors LP Ritter Pharmaceuticals Inc [2018-02-13]
Sabby Management LLC Ritter Pharmaceuticals Inc [2017-10-03]
Alyeska Investment Group LP Ritter Pharmaceuticals Inc [2017-02-14]
Knoll Capital Management LP Ritter Pharmaceuticals Inc [2016-11-04]
Knoll Capital Management LP Ritter Pharmaceuticals Inc [2016-10-05]
View All
Form 3/4/5 Subject 2011 - 2026
Ritter Pharmaceuticals Inc
Shi Chen
Wang Jiawei
Faraday Future Intelligent Electric Inc
Bensler Graydon
Braeden Lichti
Becher Campbell
Lim Robert Bradley
Price Cody
Broidrick Amy S
Sinha Shishir K
Poirier Michael S
Korenberg Matthew E
Ritter Ira E
Emery Sidney W Jr
Arshad Tariq
Kruger Kurt H
Abdul-Ahad Wajdi
Lotz Christopher L
David Richard A
Sekisui Diagnostics LLC
Ritter Andrew J
Beck John W
Foehr Matthew W
Doyle Noah
Merino William M
Maier Paul V
Step Michael D
Benjamin Jeffrey S
Proehl Gerald T
Javelin Venture Partners LP
Mochizuki Ellen F
Stonehenge Partners LLC
Javelin Venture Partners I SPV I LLC
Lynn Samuel O
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 102,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 40,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 40,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 40,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 375,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 40,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 80,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 100,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 100,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 130,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2022-07-11 Grant 40,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Common Stock
2022-06-22 Buy 30,000 $0.57 17,100
Ritter Pharmaceuticals Inc QLGN
Common Stock
2022-06-14 Buy 30,000 $0.62 18,600
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2021-12-08 Grant 300,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2021-12-08 Grant 300,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Common Stock
2021-08-19 Buy 4,000 $1.23 4,920
Ritter Pharmaceuticals Inc QLGN
Common Stock
2021-08-19 Buy 4,000 $1.22 4,880
Ritter Pharmaceuticals Inc QLGN
Stock Option (Right to Buy) · derivative
2021-05-17 Grant 100,000 $0.00
Ritter Pharmaceuticals Inc QLGN
Common Stock
2021-04-26 Buy 4,500 $2.03 9,135
Ritter Pharmaceuticals Inc QLGN
Common Stock
2021-04-20 Buy 11,005 $1.80 19,809
showing 20 of 138 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com